United States Metastatic Bone Tumor Treatment Market Report 2017

May 2017 | 98 pages | ID: U4A8A2ECF38EN
QYResearch

Abstracts

In this report, the United States Metastatic Bone Tumor Treatment market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Metastatic Bone Tumor Treatment in these regions, from 2012 to 2022 (forecast).

United States Metastatic Bone Tumor Treatment market competition by top manufacturers/players, with Metastatic Bone Tumor Treatment sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Novartis AG
• Amgen Inc
• Catena Pharmaceuticals
• Hoffmann-La Roche Ltd
• Eli Lilly
• Pfizer

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• External Radiation Therapy
• chemotherapy
• Hormone Therapy
• Immunotherapy
• Medications
• Surgical treatment

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Metastatic Bone Tumor Treatment for each application, including

• Hospitals
• Cancer Rehabilitation Centers
• Specialty Clinics
• Ambulatory Surgical Centers

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Metastatic Bone Tumor Treatment Market Report 2017

1 METASTATIC BONE TUMOR TREATMENT OVERVIEW

1.1 Product Overview and Scope of Metastatic Bone Tumor Treatment
1.2 Classification of Metastatic Bone Tumor Treatment by Product Category
  1.2.1 United States Metastatic Bone Tumor Treatment Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Metastatic Bone Tumor Treatment Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 External Radiation Therapy
  1.2.4 chemotherapy
  1.2.5 Hormone Therapy
  1.2.6 Immunotherapy
  1.2.7 Medications
  1.2.8 Surgical treatment
1.3 United States Metastatic Bone Tumor Treatment Market by Application/End Users
  1.3.1 United States Metastatic Bone Tumor Treatment Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hospitals
  1.3.3 Cancer Rehabilitation Centers
  1.3.4 Specialty Clinics
  1.3.5 Ambulatory Surgical Centers
1.4 United States Metastatic Bone Tumor Treatment Market by Region
  1.4.1 United States Metastatic Bone Tumor Treatment Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Metastatic Bone Tumor Treatment Status and Prospect (2012-2022)
  1.4.3 Southwest Metastatic Bone Tumor Treatment Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Metastatic Bone Tumor Treatment Status and Prospect (2012-2022)
  1.4.5 New England Metastatic Bone Tumor Treatment Status and Prospect (2012-2022)
  1.4.6 The South Metastatic Bone Tumor Treatment Status and Prospect (2012-2022)
  1.4.7 The Midwest Metastatic Bone Tumor Treatment Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Metastatic Bone Tumor Treatment (2012-2022)
  1.5.1 United States Metastatic Bone Tumor Treatment Sales and Growth Rate (2012-2022)
  1.5.2 United States Metastatic Bone Tumor Treatment Revenue and Growth Rate (2012-2022)

2 UNITED STATES METASTATIC BONE TUMOR TREATMENT MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Metastatic Bone Tumor Treatment Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Metastatic Bone Tumor Treatment Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Metastatic Bone Tumor Treatment Average Price by Players/Suppliers (2012-2017)
2.4 United States Metastatic Bone Tumor Treatment Market Competitive Situation and Trends
  2.4.1 United States Metastatic Bone Tumor Treatment Market Concentration Rate
  2.4.2 United States Metastatic Bone Tumor Treatment Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Metastatic Bone Tumor Treatment Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES METASTATIC BONE TUMOR TREATMENT SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Metastatic Bone Tumor Treatment Sales and Market Share by Region (2012-2017)
3.2 United States Metastatic Bone Tumor Treatment Revenue and Market Share by Region (2012-2017)
3.3 United States Metastatic Bone Tumor Treatment Price by Region (2012-2017)

4 UNITED STATES METASTATIC BONE TUMOR TREATMENT SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Metastatic Bone Tumor Treatment Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Metastatic Bone Tumor Treatment Revenue and Market Share by Type (2012-2017)
4.3 United States Metastatic Bone Tumor Treatment Price by Type (2012-2017)
4.4 United States Metastatic Bone Tumor Treatment Sales Growth Rate by Type (2012-2017)

5 UNITED STATES METASTATIC BONE TUMOR TREATMENT SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Metastatic Bone Tumor Treatment Sales and Market Share by Application (2012-2017)
5.2 United States Metastatic Bone Tumor Treatment Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES METASTATIC BONE TUMOR TREATMENT PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Novartis AG
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Metastatic Bone Tumor Treatment Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Novartis AG Metastatic Bone Tumor Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Amgen Inc
  6.2.2 Metastatic Bone Tumor Treatment Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Amgen Inc Metastatic Bone Tumor Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Catena Pharmaceuticals
  6.3.2 Metastatic Bone Tumor Treatment Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Catena Pharmaceuticals Metastatic Bone Tumor Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Hoffmann-La Roche Ltd
  6.4.2 Metastatic Bone Tumor Treatment Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Hoffmann-La Roche Ltd Metastatic Bone Tumor Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Eli Lilly
  6.5.2 Metastatic Bone Tumor Treatment Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Eli Lilly Metastatic Bone Tumor Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Pfizer
  6.6.2 Metastatic Bone Tumor Treatment Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Pfizer Metastatic Bone Tumor Treatment Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview

7 METASTATIC BONE TUMOR TREATMENT MANUFACTURING COST ANALYSIS

7.1 Metastatic Bone Tumor Treatment Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Metastatic Bone Tumor Treatment

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Metastatic Bone Tumor Treatment Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Metastatic Bone Tumor Treatment Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES METASTATIC BONE TUMOR TREATMENT MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Metastatic Bone Tumor Treatment Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Metastatic Bone Tumor Treatment Sales Volume Forecast by Type (2017-2022)
11.3 United States Metastatic Bone Tumor Treatment Sales Volume Forecast by Application (2017-2022)
11.4 United States Metastatic Bone Tumor Treatment Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Metastatic Bone Tumor Treatment
Figure United States Metastatic Bone Tumor Treatment Market Size (K Units) by Type (2012-2022)
Figure United States Metastatic Bone Tumor Treatment Sales Volume Market Share by Type (Product Category) in 2016
Figure External Radiation Therapy Product Picture
Figure chemotherapy Product Picture
Figure Hormone Therapy Product Picture
Figure Immunotherapy Product Picture
Figure Medications Product Picture
Figure Surgical treatment Product Picture
Figure United States Metastatic Bone Tumor Treatment Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Metastatic Bone Tumor Treatment by Application in 2016
Figure Hospitals Examples
Figure Cancer Rehabilitation Centers Examples
Figure Specialty Clinics Examples
Figure Ambulatory Surgical Centers Examples
Figure United States Metastatic Bone Tumor Treatment Market Size (Million USD) by Region (2012-2022)
Figure The West Metastatic Bone Tumor Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Metastatic Bone Tumor Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Metastatic Bone Tumor Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Metastatic Bone Tumor Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Metastatic Bone Tumor Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Metastatic Bone Tumor Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Metastatic Bone Tumor Treatment Sales (K Units) and Growth Rate (2012-2022)
Figure United States Metastatic Bone Tumor Treatment Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Metastatic Bone Tumor Treatment Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Metastatic Bone Tumor Treatment Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Metastatic Bone Tumor Treatment Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Metastatic Bone Tumor Treatment Sales Share by Players/Suppliers
Figure 2017 United States Metastatic Bone Tumor Treatment Sales Share by Players/Suppliers
Figure United States Metastatic Bone Tumor Treatment Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Metastatic Bone Tumor Treatment Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Metastatic Bone Tumor Treatment Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Metastatic Bone Tumor Treatment Revenue Share by Players/Suppliers
Figure 2017 United States Metastatic Bone Tumor Treatment Revenue Share by Players/Suppliers
Table United States Market Metastatic Bone Tumor Treatment Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Metastatic Bone Tumor Treatment Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Metastatic Bone Tumor Treatment Market Share of Top 3 Players/Suppliers
Figure United States Metastatic Bone Tumor Treatment Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Metastatic Bone Tumor Treatment Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Metastatic Bone Tumor Treatment Product Category
Table United States Metastatic Bone Tumor Treatment Sales (K Units) by Region (2012-2017)
Table United States Metastatic Bone Tumor Treatment Sales Share by Region (2012-2017)
Figure United States Metastatic Bone Tumor Treatment Sales Share by Region (2012-2017)
Figure United States Metastatic Bone Tumor Treatment Sales Market Share by Region in 2016
Table United States Metastatic Bone Tumor Treatment Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Metastatic Bone Tumor Treatment Revenue Share by Region (2012-2017)
Figure United States Metastatic Bone Tumor Treatment Revenue Market Share by Region (2012-2017)
Figure United States Metastatic Bone Tumor Treatment Revenue Market Share by Region in 2016
Table United States Metastatic Bone Tumor Treatment Price (USD/Unit) by Region (2012-2017)
Table United States Metastatic Bone Tumor Treatment Sales (K Units) by Type (2012-2017)
Table United States Metastatic Bone Tumor Treatment Sales Share by Type (2012-2017)
Figure United States Metastatic Bone Tumor Treatment Sales Share by Type (2012-2017)
Figure United States Metastatic Bone Tumor Treatment Sales Market Share by Type in 2016
Table United States Metastatic Bone Tumor Treatment Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Metastatic Bone Tumor Treatment Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Metastatic Bone Tumor Treatment by Type (2012-2017)
Figure Revenue Market Share of Metastatic Bone Tumor Treatment by Type in 2016
Table United States Metastatic Bone Tumor Treatment Price (USD/Unit) by Types (2012-2017)
Figure United States Metastatic Bone Tumor Treatment Sales Growth Rate by Type (2012-2017)
Table United States Metastatic Bone Tumor Treatment Sales (K Units) by Application (2012-2017)
Table United States Metastatic Bone Tumor Treatment Sales Market Share by Application (2012-2017)
Figure United States Metastatic Bone Tumor Treatment Sales Market Share by Application (2012-2017)
Figure United States Metastatic Bone Tumor Treatment Sales Market Share by Application in 2016
Table United States Metastatic Bone Tumor Treatment Sales Growth Rate by Application (2012-2017)
Figure United States Metastatic Bone Tumor Treatment Sales Growth Rate by Application (2012-2017)
Table Novartis AG Basic Information List
Table Novartis AG Metastatic Bone Tumor Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Novartis AG Metastatic Bone Tumor Treatment Sales Growth Rate (2012-2017)
Figure Novartis AG Metastatic Bone Tumor Treatment Sales Market Share in United States (2012-2017)
Figure Novartis AG Metastatic Bone Tumor Treatment Revenue Market Share in United States (2012-2017)
Table Amgen Inc Basic Information List
Table Amgen Inc Metastatic Bone Tumor Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Amgen Inc Metastatic Bone Tumor Treatment Sales Growth Rate (2012-2017)
Figure Amgen Inc Metastatic Bone Tumor Treatment Sales Market Share in United States (2012-2017)
Figure Amgen Inc Metastatic Bone Tumor Treatment Revenue Market Share in United States (2012-2017)
Table Catena Pharmaceuticals Basic Information List
Table Catena Pharmaceuticals Metastatic Bone Tumor Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Catena Pharmaceuticals Metastatic Bone Tumor Treatment Sales Growth Rate (2012-2017)
Figure Catena Pharmaceuticals Metastatic Bone Tumor Treatment Sales Market Share in United States (2012-2017)
Figure Catena Pharmaceuticals Metastatic Bone Tumor Treatment Revenue Market Share in United States (2012-2017)
Table Hoffmann-La Roche Ltd Basic Information List
Table Hoffmann-La Roche Ltd Metastatic Bone Tumor Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Hoffmann-La Roche Ltd Metastatic Bone Tumor Treatment Sales Growth Rate (2012-2017)
Figure Hoffmann-La Roche Ltd Metastatic Bone Tumor Treatment Sales Market Share in United States (2012-2017)
Figure Hoffmann-La Roche Ltd Metastatic Bone Tumor Treatment Revenue Market Share in United States (2012-2017)
Table Eli Lilly Basic Information List
Table Eli Lilly Metastatic Bone Tumor Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Eli Lilly Metastatic Bone Tumor Treatment Sales Growth Rate (2012-2017)
Figure Eli Lilly Metastatic Bone Tumor Treatment Sales Market Share in United States (2012-2017)
Figure Eli Lilly Metastatic Bone Tumor Treatment Revenue Market Share in United States (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Metastatic Bone Tumor Treatment Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Pfizer Metastatic Bone Tumor Treatment Sales Growth Rate (2012-2017)
Figure Pfizer Metastatic Bone Tumor Treatment Sales Market Share in United States (2012-2017)
Figure Pfizer Metastatic Bone Tumor Treatment Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Metastatic Bone Tumor Treatment
Figure Manufacturing Process Analysis of Metastatic Bone Tumor Treatment
Figure Metastatic Bone Tumor Treatment Industrial Chain Analysis
Table Raw Materials Sources of Metastatic Bone Tumor Treatment Major Players/Suppliers in 2016
Table Major Buyers of Metastatic Bone Tumor Treatment
Table Distributors/Traders List
Figure United States Metastatic Bone Tumor Treatment Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Metastatic Bone Tumor Treatment Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Metastatic Bone Tumor Treatment Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Metastatic Bone Tumor Treatment Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Metastatic Bone Tumor Treatment Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Metastatic Bone Tumor Treatment Sales Volume (K Units) Forecast by Type in 2022
Table United States Metastatic Bone Tumor Treatment Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Metastatic Bone Tumor Treatment Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Metastatic Bone Tumor Treatment Sales Volume (K Units) Forecast by Application in 2022
Table United States Metastatic Bone Tumor Treatment Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Metastatic Bone Tumor Treatment Sales Volume Share Forecast by Region (2017-2022)
Figure United States Metastatic Bone Tumor Treatment Sales Volume Share Forecast by Region (2017-2022)
Figure United States Metastatic Bone Tumor Treatment Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources